Effect of placental malaria and HIV infection on the antibody responses to Plasmodium falciparum in infants

Journal of Infectious Diseases

Volumn 198, Issue 11, 2008, Pages 1609-1619

  Ned, Renée M ^a,g   Price, April E ^a,h   Crawford, Sara B ^a,b,i   Ayisi, John G ^d   Van Eijk, Anna Maria ^d   Otieno, Juliana A ^e   Nahlen, Bernard L ^f   Steketee, Richard W ^a   Slutsker, Laurence ^a   Shi, Ya Ping ^a   Lanar, David E ^c   Udhayakumar, Venkatachalam ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^e New Nyanza Provincial General Hospital   (Kenya)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ VALPARAISO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CIRCUMSPOROZOITE PROTEIN; ERYTHROCYTE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; LIVER ANTIGEN; MEROZOITE SURFACE PROTEIN 2; PARASITE ANTIBODY; PARASITE ANTIGEN; RAP1 PROTEIN; TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; MORBIDITY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGING; ANIMALS; ANTIBODIES, PROTOZOAN; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; KENYA; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

EID: 56649119075     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593066     Document Type: Article

References (41)

1. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001; 64:28-35.
2. Le Hesran JY, Cot M, Personne P, et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol 1997; 146:826-31.
3. van Eijk AM, Ayisi JG, Ter Kuile FO, et al. Malaria and human immunodeficiency virus infection as risk factors for anemia in infants in Kisumu, western Kenya. Am J Trop Med Hyg 2002; 67:44-53.
4. Bonner PC, Zhou Z, Mirel LB, et al. Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic. Clin Diagn Lab Immunol 2005; 12:375-9.
5. Mutabingwa TK, Bolla MC, Li JL, et al. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med 2005; 2:e407.
6. Slutsker L, Marston BJ. HIV and malaria: interactions and implications. Curr Opin Infect Dis 2007; 20:3-10.
7. ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2004; 71:41-54.
8. Ned RM, Moore JM, Chaisavaneeyakorn S, Udhayakumar V. Modulation of immune responses during HIV-malaria co-infection in pregnancy. Trends Parasitol 2005; 21:284-91.
9. Ayisi JG, van Eijk AM, Newman RD, et al. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 2004; 10:643-652.
10. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 2003; 17:2539-41.
11. Inion I, Mwanyumba F, Gaillard P, et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003; 188:1675-8.
12. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 1995; 9:721-6.
13. Ticconi C, Mapfumo M, Dorrucci M, et al. Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe. J Acquir Immune Defic Syndr 2003; 34:289-94.
14. Verhoeff FH, Le Cessie S, Kalanda BF, Kazembe PN, Broadhead RL, Brabin BJ. Post-neonatal infant mortality in Malawi: the importance of maternal health. Ann Trop Paediatr 2004; 24:161-9.
15. van Eijk AM, Ayisi JG, Ter Kuile FO, et al. HIV, malaria, and infant anemia as risk factors for postneonatal infant mortality among HIV-seropositive women in Kisumu, Kenya. J Infect Dis 2007; 196:30-7.
16. Ismaili J, van der Sande M, Holland MJ, et al. Plasmodium falciparum infection of the placenta affects newborn immune responses. Clin Exp Immunol 2003; 133:414-21.
17. De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergamma-globulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-6.
18. de Moraes-Pinto MI, Almeida AC, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173:1077-84.
19. Scott S, Cumberland P, Shulman CE, et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 2005; 191:1854-60.
20. Ayisi JG, Branch OH, Rafi-Janajreh A, et al. Does infection with human immunodeficiency virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? J Infect 2003; 46:164-72.
21. Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004; 363:1860-7.
22. Ayisi JG, van Eijk AM, ter Kuile FO, et al. Risk factors for HIV infection among asymptomatic pregnant women attending an antenatal clinic in western Kenya. Int J STD AIDS 2000; 11:393-401.
23. Hillier CJ, Ware LA, Barbosa A, et al. Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Infect Immun 2005; 73:2109-15
24. Ockenhouse CF, Barbosa A, Blackall DP, et al. Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A. Mol Biochem Parasitol 2001; 113:9-21.
25. Dutta S, Lalitha PV, Ware LA, et al. Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect Immun 2002; 70:3101-10.
26. Zhou Z, Xiao L, Branch OH, Kariuki S, Nahlen BL, Lal AA. Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project. Am J Trop Med Hyg 2002; 66:7-12.
27. Otieno RO, Ouma C, Ong'echa JM, et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 2006; 20:275-80.
28. Dent A, Malhotra I, Mungai P, et al. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy. J Immunol 2006; 177:7139-45.
29. Brustoski K, Kramer M, Möller U, Kremsner PG, Luty AJ. Neonatal and maternal immunological responses to conserved epitopes within the DBL-γ3 chondroitin sulfate A-binding domain of Plasmodium falciparum erythrocyte membrane protein 1. Infect Immun 2005; 73:7988-95.
30. Desowitz RS. Prenatal immune priming in malaria: antigen-specific blastogenesis of cord blood lymphocytes from neonates born in a setting of holoendemic malaria. Ann Trop Med Parasitol 1988; 82:121-5.
31. King CL, Malhotra I, Wamachi A, et al. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol 2002; 168:356-64.
32. Xi G, Leke RG, Thuita LW, et al. Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies. Infect Immun 2003; 71:1242-6.
33. Cumberland P, Shulman CE, Maple PA, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 2007; 196:550-7.
34. de Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79:F202-5.
35. Schofield L, Uadia P. Lack of Ir gene control in the immune response to malaria. I. A thymus-independent antibody response to the repetitive surface protein of sporozoites. J Immunol 1990; 144:2781-8.
36. Madhi SA, Kuwanda L, Cutland C, Holm A, Käyhty H, Klugman KP. Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2005; 24:410-6.
37. Thaithumyanon P, Punnahitananda S, Praisuwanna P, Thisyakorn U, Ruxrungtham K. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers. J Med Assoc Thai 2002; 85:277-82.
38. Cot M, Le Hesran JY, Staalsoe T, Fievet N, Hviid L, Deloron P. Maternally transmitted antibodies to pregnancy-associated variant antigens on the surface of erythrocytes infected with Plasmodium falciparum: relation to child susceptibility to malaria. Am J Epidemiol 2003; 157:203-9.
39. Riley EM, Wagner GE, Ofori MF, et al. Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun 2000; 68:5856-63.
40. Riley EM, Wagner GE, Akanmori BD, Koram KA. Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol 2001; 23:51-9.
41. Cavanagh DR, Dodoo D, Hviid L, et al. Antibodies to the N-terminal block 2of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect Immun 2004; 72:6492-502.